Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IVOSIDENIB for Chondrosarcoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 12 adverse event reports in the FDA FAERS database where IVOSIDENIB was used for Chondrosarcoma.

Most Reported Side Effects for IVOSIDENIB

Side Effect Reports % Deaths Hosp.
Off label use 613 36.2% 31 96
Fatigue 144 8.5% 6 17
Diarrhoea 100 5.9% 4 17
Nausea 100 5.9% 5 27
Disease progression 86 5.1% 19 9
Differentiation syndrome 80 4.7% 22 46
Product dose omission issue 68 4.0% 0 16
Drug ineffective 64 3.8% 12 13
Platelet count decreased 61 3.6% 3 27
Electrocardiogram qt prolonged 58 3.4% 3 19
Pneumonia 51 3.0% 9 40
Vomiting 51 3.0% 4 26
Asthenia 49 2.9% 6 17
Febrile neutropenia 48 2.8% 7 43
Product use issue 43 2.5% 4 13

Other Indications for IVOSIDENIB

Acute myeloid leukaemia (729) Cholangiocarcinoma (277) Product used for unknown indication (194) Brain neoplasm malignant (140) Myelodysplastic syndrome (65) Off label use (27) Astrocytoma (20) Bone cancer (19) Glioma (16) Bile duct cancer (15)

Other Drugs Used for Chondrosarcoma

CABOZANTINIB S-MALATE (146) DOXORUBICIN (42) PAZOPANIB (32) IFOSFAMIDE (28) CISPLATIN (22) VISMODEGIB (19) NIVOLUMAB (17) BELINOSTAT (12) CYCLOPHOSPHAMIDE (11) METHOTREXATE (10)

Related Pages

IVOSIDENIB Full Profile All Chondrosarcoma Drugs IVOSIDENIB Demographics IVOSIDENIB Timeline